CONFIDENTIAL SETTLEMENT AGREEMENT AND MUTUAL RELEASEConfidential Settlement Agreement • July 18th, 2022 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Confidential Settlement Agreement and Mutual Release (the “Agreement”) is entered into effective as of July 15, 2022 (the “Effective Date”) by and among Celldex Therapeutics, Inc. (“Celldex”) and Shareholder Representative Services LLC (“SRS”), in its capacity as the Stockholders representative under the Merger Agreement (defined below) and on behalf of each of the Stockholders (defined below). Each of the aforementioned parties is to be referred to as a “Party” and collectively as the “Parties.”
